| Trial ID: | L0330 |
| Source ID: | NCT01163162
|
| Associated Drug: |
Paricalcitol
|
| Title: |
The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate
|
| Acronym: |
Paricalcitol
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01163162/results
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Paricalcitol
|
| Outcome Measures: |
Primary: 24-hour Urine Creatinine Excretion Rate, We expect the 24 hour urine creatinine excretion rate to show no differences between groups., 1 Week | Secondary: Creatinine Clearance, The primary outcome variable will be creatinine clearance. Subject will be used as random variable and maximal likelihood estimation methods will be used. We expect no differences between periods., 1 Week|Serum Creatinine, We expect serum creatinine to confirm the results of creatinine clearance., 1 Week
|
| Sponsor/Collaborators: |
Sponsor: Indiana University | Collaborators: Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2010-08
|
| Completion Date: |
2011-06
|
| Results First Posted: |
2013-05-21
|
| Last Update Posted: |
2013-05-21
|
| Locations: |
Roudebush VA Medical Center, Indianapolis, Indiana, 46202, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01163162
|
